Avonex Logo
Avonex Logo › Relapsing MS Patients Seen to Benefit from Ozanimod in Phase 3 Trials
47 views
140.15 KB
1000x667
Aug 8, 2019
JPG
License: not commercial use
#494D56
#FBEB71
#6D429C
#B09CD1
#CA3F3C
#90AFDE
#9469C5